These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8049289)

  • 1. [The antigenemia test for cytomegalovirus].
    Pérez JL; Salvà J; Niubó J
    Enferm Infecc Microbiol Clin; 1994 May; 12(5):251-61. PubMed ID: 8049289
    [No Abstract]   [Full Text] [Related]  

  • 2. Virological diagnosis of cytomegalovirus in renal transplantation: comparison of three diagnostic methods: DNA in plasma by PCR, PP65 leukocytic antigenemia, and viremia.
    Eckart P; Brouard J; Legoff C; Freymuth F; Duhamel JF; Ryckelynck JP; Hurault De Ligny B
    Transplant Proc; 1996 Oct; 28(5):2806-7. PubMed ID: 8908069
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
    Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
    Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation.
    Hebart H; Müller C; Löffler J; Jahn G; Einsele H
    Bone Marrow Transplant; 1996 May; 17(5):861-8. PubMed ID: 8733710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison between 2 monoclonal antibodies (clones 95/12 and 1C3 + AYm-1) for the detection of pp65 antigenemia associated with human cytomegalovirus].
    Reina J; Munar M; Blanco I
    Enferm Infecc Microbiol Clin; 1998; 16(6):269-71. PubMed ID: 9763743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
    Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
    Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multisite trial comparing two cytomegalovirus (CMV) pp65 antigenemia test kits, biotest CMV brite and Bartels/Argene CMV antigenemia.
    St George K; Boyd MJ; Lipson SM; Ferguson D; Cartmell GF; Falk LH; Rinaldo CR; Landry ML
    J Clin Microbiol; 2000 Apr; 38(4):1430-3. PubMed ID: 10747120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of the cytomegalovirus (CMV) antigenemia assay for predicting the occurrence of CMV disease and death in patients with AIDS.
    Chevret S; Scieux C; Garrait V; Dahel L; Morinet F; Modaï J; Decazes JM; Molina JM
    Clin Infect Dis; 1999 Apr; 28(4):758-63. PubMed ID: 10825035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of viral culture, pp-65 antigenemia, and polymerase chain reaction for the detection of cytomegalovirus in blood specimens from renal transplant recipients.
    Segondy M; Mourad G; Boumzebra A; Montes B; Leray H
    Transplant Proc; 1996 Oct; 28(5):2810. PubMed ID: 8908071
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients.
    Mhiri L; Kaabi B; Houimel M; Arrouji Z; Slim A
    J Virol Methods; 2007 Jul; 143(1):23-8. PubMed ID: 17336402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between RFLP-PCR and antigenemia for pp65 antigen for diagnosis of cytomegalovirus disease after kidney transplantation.
    Schröeder R; Michelon T; Fagundes I; Bortolotto A; Petry M; Lammerhirt E; Santos L; Cantarelli V; Keitel E; Garcia V; Neumann J
    Transplant Proc; 2004 May; 36(4):891-3. PubMed ID: 15194306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blinded, prospective study to define antigenemia and quantitative real-time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients.
    David-Neto E; Triboni AH; Paula FJ; Vilas Boas LS; Machado CM; Agena F; Latif AZ; Alencar CS; Pierrotti LC; Nahas WC; Caiaffa-Filho HH; Pannuti CS
    Transplantation; 2014 Nov; 98(10):1077-81. PubMed ID: 24839894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of cytomegalovirus after solid-organ transplantation: comparison of pp65 antigenemia assay with a quantitative DNA hybridization assay.
    Bossart W; Bienz K; Wunderli W
    J Clin Microbiol; 1997 Dec; 35(12):3303-4. PubMed ID: 9399540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of CMV Brite kit for detection of cytomegalovirus pp65 antigenemia in peripheral blood leukocytes by immunofluorescence.
    Landry ML; Ferguson D; Stevens-Ayers T; de Jonge MW; Boeckh M
    J Clin Microbiol; 1996 May; 34(5):1337-9. PubMed ID: 8727936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte concentration in the performance of the pp65 antigenemia assay.
    Lipson SM; Della-Latta P
    J Clin Microbiol; 2000 Aug; 38(8):3137-8. PubMed ID: 11001666
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients.
    Matsunaga T; Sakamaki S; Ishigaki S; Kohda K; Takeda M; Katoh J; Kuroda H; Hirayama Y; Kusakabe T; Akiyama T; Kuga T; Niitsu Y; Masaoka T; Sagawa T; Matsumoto Y
    Int J Hematol; 1999 Feb; 69(2):105-11. PubMed ID: 10071460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival.
    Eriksson BM; Wirgart BZ; Claesson K; Tufveson G; Magnusson G; Tötterman T; Grillner L
    Clin Transplant; 1996 Dec; 10(6 Pt 1):494-502. PubMed ID: 8996769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.